On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. Mologic works with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.
Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology.
The creativity, insight and knowledge that led to that ground breaking invention has guided Mologic since their formation in 2003, and they’ve been behind some of the most important innovations in rapid point-of-care diagnosis since then.
Mologic offers an extensive portfolio of device and reagent products for clinical and commercial applications along with world-leading scientific research expertise for your contract R&D requirements.
With their help, you can scale up manufacture from initial prototyping through low- to mid-scale production.
Whatever stage your point-of-care diagnostic product is at, they can help move it to the next level and beyond.
